PBMs 2022 Annual Review

$249.00

The 2022 PBM Annual Review, 175 pages, offers comprehensive intelligence on 55 PBM companies. The report identifies and segments the market into Market Leaders, Mid-Market PBMs, and the growing segment of Non-Traditional PBMs. AMI’s report also provides a brief background on the market.

Each PBM company profile includes: company background, company strategy, top executives, financial results/company investors, extensive products and services, and recent activities.

AMI monitors and reports on the pharmaceutical benefit management market on a continuing basis and works with clients to provide the market intelligence they need to be successful.